| Application no. and date | 00960112.1 (espacenet) (Federated) (European Patent Register), 20000621 | | Patent/reg. no. and date | DK/EP 1189916, 20031210 | | Publication date | 20020327 | | Priority no. and date | US 338185, 19990622 | | EP pub. no. and date |
EP 1189916 20020327 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, California 94404, US | | Applicant ref. no. | P200301926 EP DK | | Inventor | ELZEIN, Elfatih, O., 4644 Creekwood Drive
Freemont, CA 94555, US,
ZABLOCKI, Jeff, A., 580 Sleeper Avenue
Mountain View, CA 94040, US,
PALLE, Venkata, P., 600 Rainbow Drive
Mountain View, CA 94041, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7076 (2006.01) , A61K 49/00 (2006.01) , A61P 9/00 (2006.01) , C07H 19/16 (2006.01) | | Title | N-pyrazol A 2A-receptoragonister | | Int. application no. | US2000040281 | | Int. publication no. | WO2000078779 | | Related patent (certificate) | CA 2011 00005 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
